T-cell lymphomas: ATLL, mycosis fungoides, PTCL, ALCL
- Look-alikes compared
T-cell lymphomas are rarer than B-cell ones and often pose as a rash, an infection or high calcium. On the Colombian Pacific, HTLV-1 makes one a local disease.
What it is
Mature T-cell and NK-cell lymphomas are a mixed group of about one in ten lymphomas. The ones a clinician meets are adult T-cell leukaemia/lymphoma (ATLL), caused by the retrovirus HTLV-1; mycosis fungoides and Sézary syndrome, which live in the skin and blood; peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) and angioimmunoblastic T-cell lymphoma (AITL), which live in the nodes; and anaplastic large cell lymphoma (ALCL), defined by strong CD30 and split by whether it carries an ALK rearrangement. Except for ALK-positive ALCL and early mycosis fungoides, most behave aggressively and respond less well to treatment than B-cell lymphomas.
The difference in one line
- ATLL: a CD4+ CD25+ T-cell cancer in a small minority of lifelong HTLV-1 carriers, decades after infection that is usually acquired by breastfeeding; four forms: acute, lymphoma, chronic and smouldering.
- ATLL clues: 'flower cells' (lobulated nuclei) on the smear, high calcium with lytic bone lesions, skin lesions and opportunistic infections such as Strongyloides hyperinfection and Pneumocystis.
- Mycosis fungoides: the commonest cutaneous T-cell lymphoma; patches and plaques on covered skin for years, often first called eczema or psoriasis; Sézary syndrome is the leukaemic form with red skin all over and nodes.
- PTCL-NOS: the commonest nodal T-cell lymphoma, a diagnosis of exclusion; AITL is the T-follicular-helper type with rash, high polyclonal antibodies, autoimmune haemolysis and EBV-positive B cells in the node.
- ALCL: large 'hallmark' cells with horseshoe nuclei and strong CD30; ALK-positive (often NPM1::ALK, t(2;5)) in children and young adults has the best outlook of the T-cell lymphomas; ALK-negative is older and worse.
- Extranodal NK/T-cell lymphoma, nasal type, is EBV-driven, destroys the nose and palate and is more common in East Asia and Latin America; enteropathy-associated T-cell lymphoma complicates coeliac disease.
The four T-cell lymphomas most often confused
| Feature | ATLL | Mycosis fungoides / Sézary | PTCL-NOS and AITL | ALCL |
|---|---|---|---|---|
| Driver | HTLV-1 retrovirus | Skin-homing T cells; no virus | None named (NOS); T-follicular-helper programme (AITL) | ALK fusion (ALK+) or other changes (ALK−) |
| Typical patient | Adult born where HTLV-1 is endemic (Pacific coast, Japan, Caribbean) | Older adult with a long-standing 'eczema' | Older adult with nodes and B symptoms; AITL with rash and itch | ALK+: child or young adult; ALK−: older adult |
| Where it shows | Blood, nodes, skin, bone (high calcium) | Skin first; blood and nodes late (Sézary) | Nodes, liver, spleen, marrow | Nodes, skin, soft tissue; implant seroma (breast implant-associated type) |
| Key test | HTLV-1 serology; flower cells; CD4+ CD25+ | Repeated skin biopsies; CD4+ with loss of CD7; Sézary cells in blood | Node biopsy; T-cell clonality; TFH markers and EBV in AITL | Strong uniform CD30; ALK staining |
| Course | Acute and lymphoma forms very aggressive; chronic and smouldering slower | Indolent for years if limited to patches | Aggressive, frequent relapse | ALK+ often curable; ALK− less so |
| Treatment principle | Antiviral plus interferon in leukaemic forms; chemotherapy in the lymphoma form; allogeneic transplant in fit patients | Skin-directed (topical, phototherapy, radiotherapy) first; systemic only when advanced | Anthracycline-based combination chemotherapy; transplant consolidation in some | Anti-CD30 antibody–drug conjugate with chemotherapy; ALK inhibitors at relapse |
In clinical practice
- Hypercalcaemia with a high lymphocyte count and odd lobulated cells in an adult from Tumaco, Buenaventura or Quibdó should prompt HTLV-1 serology the same day.
- Before any steroid or chemotherapy in a person with HTLV-1 or a Strongyloides exposure, treat or exclude Strongyloides: immunosuppression can trigger a fatal hyperinfection.
- HTLV-1 also causes tropical spastic paraparesis; a patient with ATLL may have it, and family members may be carriers who should be offered testing and counselling on breastfeeding.
- A persistent 'eczema' or 'psoriasis' that does not respond and sits on covered skin (buttocks, trunk, thighs) deserves a biopsy, often more than one, before mycosis fungoides is excluded.
- A late fluid collection around a textured breast implant needs fluid sent for cytology and CD30, looking for breast implant-associated ALCL.
How it is confirmed
- Excision or core biopsy with immunohistochemistry (CD3, CD4, CD8, CD30, ALK, TFH markers) and T-cell receptor clonality studies.
- HTLV-1 antibody screen with confirmation in every adult T-cell lymphoma from an endemic area, plus calcium, LDH and a smear for flower cells.
- Suspected Sézary syndrome: flow cytometry of the blood for CD4+ cells lacking CD7 or CD26.
- EBV in the tissue (EBER) for nasal NK/T-cell lymphoma and AITL; plasma EBV DNA helps follow the NK/T type.
- Before treatment: HIV, hepatitis B and C, and Strongyloides serology or stool testing.
Common traps
- Treating a resistant 'eczema' on the buttocks for years: covered-skin patches that will not settle need a biopsy for mycosis fungoides
- Reading CD30 positivity as Hodgkin lymphoma: ALCL is strongly CD30 positive too, but it is a T-cell tumour without the Reed–Sternberg background
- Giving steroids to an HTLV-1 carrier without checking for Strongyloides: immunosuppression can turn a silent worm into a fatal hyperinfection
- Thinking all T-cell lymphomas have a poor outlook: ALK-positive ALCL in a young person is often cured
- Blaming high calcium in a lymphoma patient on bone metastases: in ATLL it comes from the tumour cells themselves and points straight at the diagnosis
Test yourself
Think of the answer, then tap the question to see it.
A 52-year-old woman from Buenaventura has confusion, a calcium far above normal, a high lymphocyte count and lobulated 'flower' cells on the smear. Which test confirms the likely cause?
HTLV-1 serology with confirmation: the picture is adult T-cell leukaemia/lymphoma, a CD4+ CD25+ cancer caused by HTLV-1, endemic on the Colombian Pacific coast.
A man has had a scaly, itchy patch on his buttocks and trunk for six years that has not responded to steroid creams. What is the next step, and why?
Skin biopsy, repeated if needed, because mycosis fungoides imitates eczema or psoriasis for years and favours covered skin; early biopsies can be non-diagnostic.
A 19-year-old has fast-growing nodes; the biopsy shows large cells with horseshoe nuclei, strongly CD30 positive. Which stain matters most for the outlook?
ALK: ALK-positive anaplastic large cell lymphoma in a young person has a much better prognosis than the ALK-negative type.
Why must Strongyloides be treated or excluded before steroids in an HTLV-1 carrier?
HTLV-1 shifts immunity away from the response that controls the worm, and steroids remove the rest; the larvae can then multiply and spread, carrying gut bacteria into the blood.
Elsewhere in DurgiPedia
- Nodal T-cell lymphomas
- T- and NK-cell leukaemias and extranodal lymphomas
- Mycosis fungoides, Sézary syndrome and mastocytosis
- Coeliac disease
- Clonality testing: telling lymphoma from a reactive response
- Lymphocytes and monocytes on the smear, and reactive forms
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Adult T-Cell Leukemia (StatPearls (NCBI Bookshelf), 2023); Peripheral T-Cell Lymphoma (StatPearls (NCBI Bookshelf), 2023); Anaplastic Large Cell Lymphoma (StatPearls (NCBI Bookshelf), 2023); Human T-lymphotropic virus-1 (World Health Organization (WHO), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
